This inventor holds 1 USPTO granted patent. Top assignee: National Institute of Health and Medical Research. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Pappachan Kolattukudy: Innovator in Cancer Diagnosis and Therapy
Introduction
Pappachan Kolattukudy is a notable inventor based in Columbus, OH (US). He has made significant contributions to the field of medical research, particularly in the diagnosis and therapy of cancers and paraneoplastic neurological syndromes. His innovative work has the potential to impact the lives of many patients facing these challenging conditions.
Latest Patents
Pappachan Kolattukudy holds a patent for the "Use of ULIP proteins in the diagnosis and therapy of cancers and paraneoplastic neurological syndromes." This invention involves a purified polypeptide, biologically active polypeptide derivative, or fragment of said purified polypeptide, comprising an amino acid sequence selected among SEQ.ID. No. 2, No. 4, No. 6, and No. 8. This patent highlights his commitment to advancing medical science and improving therapeutic options for patients.
Career Highlights
Pappachan Kolattukudy is associated with the Institut National de la Santé et de la Recherche Médicale, where he continues to engage in groundbreaking research. His work is characterized by a focus on innovative solutions that address critical health issues. His dedication to research and development has established him as a respected figure in his field.
Collaborations
Pappachan has collaborated with esteemed colleagues, including Michèle Aguera and Marie-Françoise Belin. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research efforts.
Conclusion
Pappachan Kolattukudy's contributions to cancer diagnosis and therapy exemplify the spirit of innovation in medical research. His patent and ongoing work reflect a commitment to improving patient outcomes through scientific advancement.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
